Andrew Volk

Andrew Volk serves as Director of Portfolio Operations at Albaron, where he partners with portfolio company leadership teams to drive operational performance, accelerate growth, and support value creation initiatives across the firm's healthcare investments.

Andrew is a seasoned healthcare executive with experience leading growth, integration, and value creation initiatives across numerous companies. Specifically, he has expertise with ambulatory infusion, specialty pharmacy, physician services, and health system-affiliated healthcare organizations. Throughout his career, he has partnered with physicians, health systems, executive leadership teams, and private equity sponsors to scale businesses, improve profitability, and execute strategic growth initiatives.

Prior to joining Albaron, Andrew served as Senior Vice President and General Manager of Infusion Services at CarepathRx, where he led growth initiatives for health system partners, developed new service offerings, and supported operational integration following the company's acquisition by Evernorth, a subsidiary of Cigna. Previously, he served as Chief Operating Officer of Talis Healthcare, where he helped scale the rapidly growing ambulatory infusion platform through operational infrastructure development, physician partnerships, and strategic growth initiatives.

Earlier in his career, Andrew held leadership positions with Infusion Associates, Corewell Health, and Mount Sinai Hospital. His experience spans payor strategy, physician practice partnerships, health system joint ventures, de novo expansion, M&A diligence and integration, revenue cycle optimization, and the development of scalable operating models designed to support long-term growth and enterprise value creation.

Andrew earned his Doctor of Pharmacy degree from Nova Southeastern University and his MBA in Finance from Cornerstone University.